Loading...

James T Mccracken

Title(s)Professor, Psychiatry and Biobehavioral Sciences
SchoolMedicine
Address760 Westwood Plaza B8-146
Los Angeles CA 90024
Phone3108250470
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    3/4-RUPP Autism Network: Guanfacine for the Treatment of Hyperactivity in PDD
    NIH R01MH083747Jul 1, 2010 - Mar 31, 2014
    Role: Principal Investigator
    OCD Collaborative Genetics Association Study
    NIH R01MH079487Sep 27, 2007 - Jul 31, 2011
    Role: Principal Investigator
    CIDAR: Translational Research to Enhance Cognitive Control (TRECC)
    NIH P50MH077248Sep 1, 2006 - Jul 31, 2011
    Role: Principal Investigator
    TRAINING THE SCIENCE OF CHILD MENTAL HEALTH TREATMENT
    NIH T32MH073517Jun 1, 2006 - Jun 30, 2022
    Role: Principal Investigator
    Drug Response in Pediatric Psychopharmacology
    NIH K24MH001805Aug 14, 2001 - Jun 30, 2006
    Role: Principal Investigator
    Follow up of the PATS Sample
    NIH U01MH060900Sep 22, 2000 - Nov 30, 2003
    Role: Principal Investigator
    DEVELOPMENTAL ASPECTS OF ANTIDEPRESSANT RESPONSES
    NIH R03MH046915Aug 1, 1990 - Jul 31, 1993
    Role: Principal Investigator
    SLEEP &HORMONE REGULATION IN JUVENILE DEPRESSION
    NIH K11MH000722Sep 30, 1987 - Aug 31, 1994
    Role: Principal Investigator
    RESEARCH UNITS ON PEDIATRIC PSYCHOPHARMACOLOGY--AUTISM-278970010
    NIH/NIMH N01MH070010Sep 30, 2000
    Role: Co-Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Defining tic severity and tic impairment in Tourette Disorder. J Psychiatr Res. 2020 Dec 13; 133:93-100. McGuire JF, Piacentini J, Storch EA, Ricketts EJ, Woods DW, Peterson AL, Walkup JT, Wilhelm S, Ramsey K, Essoe JK, Himle MB, Lewin AB, Chang S, Murphy TK, McCracken JT, Scahill L. PMID: 33338735.
      View in: PubMed   Mentions:    Fields:    
    2. Long-Term Service Use Among Youth Previously Treated for Anxiety Disorder. J Am Acad Child Adolesc Psychiatry. 2020 Dec 04. Peris TS, Sugar CA, Rozenman MS, Walkup JT, Albano AM, Compton S, Sakolsky D, Ginsburg G, Keeton C, Kendall PC, McCracken JT, Piacentini J. PMID: 33301814.
      View in: PubMed   Mentions:    Fields:    
    3. A Randomized Controlled Feasibility Trial of Reminder-Focused Positive Psychiatry in Adolescents With Comorbid Attention-Deficit/Hyperactivity Disorder and Posttraumatic Stress Disorder. Prim Care Companion CNS Disord. 2020 Sep 03; 22(5). Ahmadi N, Chaudhry S, Salam T, Rodriguez J, Kase M, Olango G, Molla M, McCracken J, Pynoos R. PMID: 32898346.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Optimizing behavior therapy for youth with Tourette's disorder. Neuropsychopharmacology. 2020 11; 45(12):2114-2119. McGuire JF, Ginder N, Ramsey K, Essoe JK, Ricketts EJ, McCracken JT, Piacentini J. PMID: 32653895.
      View in: PubMed   Mentions:    Fields:    
    5. Little Doubt That CBT Works for Pediatric OCD. J Am Acad Child Adolesc Psychiatry. 2020 Jul; 59(7):785-787. Storch EA, Peris TS, De Nadai A, Piacentini J, Bloch M, Cervin M, McGuire J, Farrell LJ, McCracken JT, McKay D, Riemann BC, Wagner AP, Franklin M, Schneider SC, Walkup JT, Williams L, Abramowitz JS, Stewart SE, Fitzgerald KD, Goodman WK. PMID: 32618273.
      View in: PubMed   Mentions:    Fields:    
    6. Neurochemical correlates of behavioral treatment of pediatric trichotillomania. J Affect Disord. 2020 08 01; 273:552-561. Peris TS, Piacentini J, Vreeland A, Salgari G, Levitt JG, Alger JR, Posse S, McCracken JT, O'Neill J. PMID: 32560953.
      View in: PubMed   Mentions:    Fields:    
    7. General personality dimensions, impairment and treatment response in obsessive-compulsive disorder. Personal Ment Health. 2020 05; 14(2):186-198. Samuels J, Bienvenu OJ, Krasnow J, Wang Y, Grados MA, Cullen B, Goes FS, Maher B, Greenberg BD, Mclaughlin NC, Rasmussen SA, Fyer AJ, Knowles JA, Mccracken JT, Piacentini J, Geller D, Stewart SE, Murphy DL, Shugart YY, Riddle MA, Nestadt G. PMID: 31859455.
      View in: PubMed   Mentions:    Fields:    
    8. Correction. J Clin Psychiatry. 2019 Oct 23; 80(5). Vitiello B, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller MB, Birmaher B, Ryan ND, Kennard B, Mayes TL, DeBar L, Lynch F, Dickerson J, Strober M, Suddath R, McCracken JT, Spirito A, Onorato M, Zelazny J, Porta G, Iyengar S, Brent DA. PMID: 31556973.
      View in: PubMed   Mentions:    Fields:    
    9. Trichotillomania comorbidity in a sample enriched for familial obsessive-compulsive disorder. Compr Psychiatry. 2019 10; 94:152123. Gerstenblith TA, Jaramillo-Huff A, Ruutiainen T, Nestadt PS, Samuels JF, Grados MA, Cullen BA, Riddle MA, Liang KY, Greenberg BD, Rasmussen SA, Rauch SL, McCracken JT, Piacentini J, Knowles JA, Nestadt G, Bienvenu OJ. PMID: 31518848.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Alpha modulation during working memory encoding predicts neurocognitive impairment in ADHD. J Child Psychol Psychiatry. 2019 08; 60(8):917-926. Lenartowicz A, Truong H, Salgari GC, Bilder RM, McGough J, McCracken JT, Loo SK. PMID: 30883769.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. What's missing in autism spectrum disorder motor assessments? J Neurodev Disord. 2018 12 13; 10(1):33. Wilson RB, McCracken JT, Rinehart NJ, Jeste SS. PMID: 30541423.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. An exploration of concomitant psychiatric disorders in children with autism spectrum disorder. Compr Psychiatry. 2019 01; 88:57-64. Lecavalier L, McCracken CE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Smith T, Johnson C, King B, Handen B, Swiezy NB, Eugene Arnold L, Bearss K, Vitiello B, Scahill L. PMID: 30504071.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    13. Changes in Sleep Problems Across Attention-Deficit/Hyperactivity Disorder Treatment: Findings from the Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder Study. J Child Adolesc Psychopharmacol. 2018 12; 28(10):690-698. Ricketts EJ, Sturm A, McMakin DL, McGuire JF, Tan PZ, Smalberg FB, McCracken JT, Colwell CS, Piacentini J. PMID: 30388029.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. The Effect of Neurocognitive Function on Math Computation in Pediatric ADHD: Moderating Influences of Anxious Perfectionism and Gender. Child Psychiatry Hum Dev. 2018 10; 49(5):822-832. Sturm A, Rozenman M, Piacentini JC, McGough JJ, Loo SK, McCracken JT. PMID: 29560540.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study. Mov Disord. 2018 08; 33(8):1272-1280. Gilbert DL, Murphy TK, Jankovic J, Budman CL, Black KJ, Kurlan RM, Coffman KA, McCracken JT, Juncos J, Grant JE, Chipkin RE. PMID: 30192018.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    16. The Interplay of Familial and Individual Risk in Predicting Clinical Improvements in Pediatric Anxiety Disorders. J Clin Child Adolesc Psychol. 2018; 47(sup1):S542-S554. Kiff CJ, Ernestus S, Gonzalez A, Kendall PC, Albano AM, Compton SN, Birmaher B, Ginsburg GS, Rynn M, Walkup JT, McCracken J, Piacentini J. PMID: 29877727.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. A multicenter examination and strategic revisions of the Yale Global Tic Severity Scale. Neurology. 2018 05 08; 90(19):e1711-e1719. McGuire JF, Piacentini J, Storch EA, Murphy TK, Ricketts EJ, Woods DW, Walkup JW, Peterson AL, Wilhelm S, Lewin AB, McCracken JT, Leckman JF, Scahill L. PMID: 29653992.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    18. Are the components of social reciprocity transdiagnostic across pediatric neurodevelopmental disorders? Evidence for common and disorder-specific social impairments. Psychiatry Res. 2018 06; 264:119-123. Sturm A, Rozenman M, Chang S, McGough JJ, McCracken JT, Piacentini JC. PMID: 29627697.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures. Neuropsychopharmacology. 2018 07; 43(8):1772-1778. PMID: 29540864.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    20. Sleep Sufficiency in Pediatric and Adolescent Tourette's Disorder: National Survey of Children's Health. J Dev Behav Pediatr. 2018 01; 39(1):72-76. Ricketts EJ, Rozenman M, Choy C, Goldberg HB, Kim JS, Colwell CS, McCracken JT, Piacentini J. PMID: 29095747.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology. J Psychopharmacol. 2018 01; 32(1):3-29. PMID: 29237331.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    22. Secondary Outcomes From the Child/Adolescent Anxiety Multimodal Study: Implications for Clinical Practice. Evid Based Pract Child Adolesc Ment Health. 2018; 3(1):30-41. Albano AM, Comer JS, Compton SN, Piacentini J, Kendall PC, Birmaher B, Walkup JT, Ginsburg GS, Rynn MA, McCracken J, Keeton C, Sakolsky DJ, Sherrill JT. PMID: 30906874.
      View in: PubMed   Mentions:
    23. Self-reported executive function and hoarding in adults with obsessive-compulsive disorder. Compr Psychiatry. 2018 02; 81:53-59. Samuels J, Bienvenu OJ, Krasnow J, Wang Y, Grados MA, Cullen B, Goes FS, Maher B, Greenberg BD, McLaughlin NC, Rasmussen SA, Fyer AJ, Knowles JA, McCracken JT, Piacentini J, Geller D, Pauls DL, Stewart SE, Murphy DL, Shugart YY, Riddle MA, Nestadt G. PMID: 29268152.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Targeted Family Intervention for Complex Cases of Pediatric Obsessive-Compulsive Disorder: A Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry. 2017 Dec; 56(12):1034-1042.e1. Peris TS, Rozenman MS, Sugar CA, McCracken JT, Piacentini J. PMID: 29173737.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    25. Therapist-Reported Features of Exposure Tasks That Predict Differential Treatment Outcomes for Youth With Anxiety. J Am Acad Child Adolesc Psychiatry. 2017 Dec; 56(12):1043-1052. PMID: 29173738.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    26. Parsing heterogeneity in attention-deficit hyperactivity disorder using EEG-based subgroups. J Child Psychol Psychiatry. 2018 03; 59(3):223-231. PMID: 28921526.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    27. Attention-memory training yields behavioral and academic improvements in children diagnosed with attention-deficit hyperactivity disorder comorbid with a learning disorder. Neuropsychiatr Dis Treat. 2017; 13:1761-1769. PMID: 28740391.
      View in: PubMed   Mentions:
    28. Evaluating the Hierarchical Structure of ADHD Symptoms and Invariance Across Age and Gender. Assessment. 2019 04; 26(3):508-523. PMID: 28621145.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. Autonomic arousal in anxious and typically developing youth during a stressor involving error feedback. Eur Child Adolesc Psychiatry. 2017 Dec; 26(12):1423-1432. PMID: 28527019.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Development and validation of an item response theory-based Social Responsiveness Scale short form. J Child Psychol Psychiatry. 2017 Sep; 58(9):1053-1061. PMID: 28464350.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    31. Child and Adolescent Adherence With Cognitive Behavioral Therapy for Anxiety: Predictors and Associations With Outcomes. J Clin Child Adolesc Psychol. 2019; 48(sup1):S215-S226. PMID: 28448176.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    32. Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study. J Child Adolesc Psychopharmacol. 2017 Aug; 27(6):501-508. PMID: 28384010.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    33. Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial. Neuropsychopharmacology. 2017 Nov; 42(12):2414-2422. PMID: 28409563.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    34. Genome Wide Association Study (GWAS) between Attention Deficit Hyperactivity Disorder (ADHD) and Obsessive Compulsive Disorder (OCD). Front Mol Neurosci. 2017; 10:83. PMID: 28386217.
      View in: PubMed   Mentions:
    35. An investigation of doubt in obsessive-compulsive disorder. Compr Psychiatry. 2017 05; 75:117-124. PMID: 28359017.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    36. Mediators of Treatment Outcomes for Anxious Children and Adolescents: The Role of Somatic Symptoms. J Clin Child Adolesc Psychol. 2018 Jan-Feb; 47(1):94-104. PMID: 28278599.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. Distinguishing Fear Versus Distress Symptomatology in Pediatric OCD. Child Psychiatry Hum Dev. 2017 02; 48(1):63-72. PMID: 27225633.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    38. A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission. J Clin Psychiatry. 2017 02; 78(2):196-206. PMID: 27314661.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    39. Sleep functioning in adults with trichotillomania (hair-pulling disorder), excoriation (skin-picking) disorder, and a non-affected comparison sample. J Obsessive Compuls Relat Disord. 2017 Apr; 13:49-57. Ricketts EJ, Snorrason I, Rozenman M, Colwell CS, McCracken JT, Piacentini J. PMID: 32467821.
      View in: PubMed   Mentions:
    40. Sex-specific associations of testosterone with prefrontal-hippocampal development and executive function. Psychoneuroendocrinology. 2017 02; 76:206-217. PMID: 27984812.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    41. Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder. J Child Adolesc Psychopharmacol. 2017 03; 27(2):125-131. PMID: 27893955.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Parental bonding and hoarding in obsessive-compulsive disorder. Compr Psychiatry. 2017 02; 73:43-52. PMID: 27915218.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder. J Child Adolesc Psychopharmacol. 2016 12; 26(10):900-908. PMID: 27726426.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder. Neuropsychopharmacology. 2017 Aug; 42(9):1914-1923. PMID: 27711048.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    45. Derisking Psychiatric Drug Development: The NIMH's Fast Fail Program, A Novel Precompetitive Model. J Clin Psychopharmacol. 2016 Oct; 36(5):419-21. PMID: 27404513.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    46. Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2016 12; 26(10):882-888. PMID: 27483130.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    47. ADHD and executive functioning deficits in OCD youths who hoard. J Psychiatr Res. 2016 11; 82:141-8. PMID: 27501140.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    48. Extinction learning in childhood anxiety disorders, obsessive compulsive disorder and post-traumatic stress disorder: implications for treatment. Expert Rev Neurother. 2016 10; 16(10):1155-74. PMID: 27275519.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    49. Cognitive Effects of Stimulant, Guanfacine, and Combined Treatment in Child and Adolescent Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2016 08; 55(8):667-73. PMID: 27453080.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    50. Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study. J Am Acad Child Adolesc Psychiatry. 2016 08; 55(8):657-666.e1. PMID: 27453079.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    51. Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2016 08; 55(8):674-682.e1. PMID: 27453081.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    52. The developmental relationship between DHEA and visual attention is mediated by structural plasticity of cortico-amygdalar networks. Psychoneuroendocrinology. 2016 08; 70:122-33. PMID: 27236606.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    53. Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder. J Am Acad Child Adolesc Psychiatry. 2016 05; 55(5):415-23. PMID: 27126856.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    54. Alpha desynchronization and fronto-parietal connectivity during spatial working memory encoding deficits in ADHD: A simultaneous EEG-fMRI study. Neuroimage Clin. 2016; 11:210-223. PMID: 26955516.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    55. Graph-theoretical analysis of resting-state fMRI in pediatric obsessive-compulsive disorder. J Affect Disord. 2016 Mar 15; 193:175-84. PMID: 26773910.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    56. Receiver Operating Characteristic Curve Analysis of Screening Tools for Bipolar Disorder Comorbid With ADHD in Schoolchildren. J Atten Disord. 2020 Aug; 24(10):1403-1412. PMID: 26721636.
      View in: PubMed   Mentions: 1     Fields:    
    57. OBSESSIVE-COMPULSIVE PERSONALITY DISORDER: EVIDENCE FOR TWO DIMENSIONS. Depress Anxiety. 2016 Feb; 33(2):128-35. PMID: 26594839.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    58. Transcranial magnetic stimulation in autism spectrum disorder: Challenges, promise, and roadmap for future research. Autism Res. 2016 Feb; 9(2):184-203. PMID: 26536383.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    59. Iron homeostasis during risperidone treatment in children and adolescents. J Clin Psychiatry. 2015 Nov; 76(11):1500-5. PMID: 26301448.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    60. Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder. Am J Psychiatry. 2015 Dec; 172(12):1197-206. PMID: 26315981.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    61. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. J Child Adolesc Psychopharmacol. 2015 Aug; 25(6):482-93. PMID: 26262903.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    62. Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up. J Am Acad Child Adolesc Psychiatry. 2015 Jul; 54(7):550-6. PMID: 26088659.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    63. Sensitivity of the modified Children's Yale-Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials. Autism. 2016 Feb; 20(2):145-52. PMID: 25882391.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    64. Predicting Anxiety Diagnoses and Severity with the CBCL-A: Improvement Relative to Other CBCL Scales? J Psychopathol Behav Assess. 2015 03 01; 37(1):100-111. PMID: 26257470.
      View in: PubMed   Mentions:
    65. Parental anxiety as a predictor of medication and CBT response for anxious youth. Child Psychiatry Hum Dev. 2015 Feb; 46(1):84-93. PMID: 24610431.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    66. Transcranial magnetic stimulation (TMS) therapy for autism: an international consensus conference held in conjunction with the international meeting for autism research on May 13th and 14th, 2014. Front Hum Neurosci. 2014; 8:1034. PMID: 25642178.
      View in: PubMed   Mentions:
    67. Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes. Pharmacogenomics. 2015 Jan; 16(1):5-22. PMID: 25560467.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    68. Child/Adolescent anxiety multimodal study: evaluating safety. J Am Acad Child Adolesc Psychiatry. 2015 Mar; 54(3):180-90. PMID: 25721183.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    69. Trajectories of change in youth anxiety during cognitive-behavior therapy. J Consult Clin Psychol. 2015 Apr; 83(2):239-52. PMID: 25486372.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    70. Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry. 2015 Jan; 172(1):82-93. PMID: 25158072.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    71. Hoarding in Children and Adolescents with Obsessive-Compulsive Disorder. J Obsessive Compuls Relat Disord. 2014 Oct 01; 3(4):325-331. PMID: 25309849.
      View in: PubMed   Mentions:
    72. Somatic complaints in anxious youth. Child Psychiatry Hum Dev. 2014 Aug; 45(4):398-407. PMID: 24129543.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    73. Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. J Am Acad Child Adolesc Psychiatry. 2014 Aug; 53(8):910-9. PMID: 25062598.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    74. Clinical correlates and genetic linkage of social and communication difficulties in families with obsessive-compulsive disorder: Results from the OCD Collaborative Genetics Study. . 2014 Jun; 165B(4):326-36. PMID: 24798771.
      View in: PubMed   Mentions:
    75. STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study. J Autism Dev Disord. 2014 Apr; 44(4):958-64. PMID: 24272415.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    76. Antipsychotic-induced weight gain: can the energy balance gene variants help us tip the scales? Pharmacogenomics. 2014 Mar; 15(4):403-6. PMID: 24624905.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    77. Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2014 Feb; 53(2):237-57. PMID: 24472258.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    78. Electroencephalography correlates of spatial working memory deficits in attention-deficit/hyperactivity disorder: vigilance, encoding, and maintenance. J Neurosci. 2014 Jan 22; 34(4):1171-82. PMID: 24453310.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    79. Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial. J Consult Clin Psychol. 2014 Apr; 82(2):212-24. PMID: 24417601.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    80. Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems. Child Adolesc Psychiatr Clin N Am. 2014 Jan; 23(1):57-72. PMID: 24231167.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    81. 24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS). J Am Acad Child Adolesc Psychiatry. 2014 Mar; 53(3):297-310. PMID: 24565357.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    82. Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial. JAMA Pediatr. 2013 Nov; 167(11):1045-52. PMID: 24061784.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    83. Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet. 2013 Oct; 9(10):e1003864. PMID: 24204291.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    84. Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist. J Am Acad Child Adolesc Psychiatry. 2014 Jan; 53(1):97-107.e1. PMID: 24342389.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    85. Exploring the manifestations of anxiety in children with autism spectrum disorders. J Autism Dev Disord. 2013 Oct; 43(10):2341-52. PMID: 23400347.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    86. A potential electroencephalography and cognitive biosignature for the child behavior checklist-dysregulation profile. J Am Acad Child Adolesc Psychiatry. 2013 Nov; 52(11):1173-82. PMID: 24157391.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    87. High-throughput cognitive assessment using BrainTest.org: examining cognitive control in a family cohort. Brain Behav. 2013 Sep; 3(5):552-61. PMID: 24392276.
      View in: PubMed   Mentions: 2     Fields:    
    88. Assessing anxiety in youth with the multidimensional anxiety scale for children. J Clin Child Adolesc Psychol. 2014; 43(4):566-78. PMID: 23845036.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    89. Up in smoke? A preliminary open-label trial of nicotine replacement therapy and cognitive behavioral motivational enhancement for smoking cessation among youth in Los Angeles. Subst Use Misuse. 2013 Dec; 48(14):1553-62. PMID: 23822739.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    90. The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youth. J Consult Clin Psychol. 2013 Oct; 81(5):859-64. PMID: 23750468.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    91. A probabilistic and individualized approach for predicting treatment gains: an extension and application to anxiety disordered youth. Behav Ther. 2014 Jan; 45(1):126-36. PMID: 24411120.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    92. Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials. J Autism Dev Disord. 2013 Mar; 43(3):739-46. PMID: 23104617.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    93. The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up. J Am Acad Child Adolesc Psychiatry. 2013 Mar; 52(3):264-278.e2. PMID: 23452683.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    94. Pilot randomized trial of bupropion for adolescent methamphetamine abuse/dependence. J Adolesc Health. 2013 Apr; 52(4):502-5. PMID: 23333007.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    95. Autism spectrum disorders: an overview on diagnosis and treatment. Braz J Psychiatry. 2013; 35 Suppl 1:S62-72. PMID: 24142129.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    96. 1H MRSI of middle frontal gyrus in pediatric ADHD. J Psychiatr Res. 2013 Apr; 47(4):505-12. PMID: 23273650.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    97. Characterization of the theta to beta ratio in ADHD: identifying potential sources of heterogeneity. J Atten Disord. 2013 Jul; 17(5):384-92. PMID: 23264365.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    98. Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale. J Am Acad Child Adolesc Psychiatry. 2013 Jan; 52(1):57-67. PMID: 23265634.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    99. Agreement between therapists, parents, patients, and independent evaluators on clinical improvement in pediatric obsessive-compulsive disorder. J Consult Clin Psychol. 2012 Dec; 80(6):1103-7. PMID: 22963592.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    100. Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI. PLoS One. 2012; 7(7):e38786. PMID: 22848344.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    101. Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders. J Autism Dev Disord. 2012 Mar; 42(3):432-40. PMID: 21667200.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    102. Genome-wide association study of intelligence: additive effects of novel brain expressed genes. J Am Acad Child Adolesc Psychiatry. 2012 Apr; 51(4):432-440.e2. PMID: 22449649.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    103. Psychopharmacology of autism spectrum disorders. Pediatr Clin North Am. 2012 Feb; 59(1):175-87, xii. PMID: 22284801.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    104. Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS. J Consult Clin Psychol. 2011 Dec; 79(6):806-13. PMID: 22122292.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    105. Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. J Child Adolesc Psychopharmacol. 2011 Dec; 21(6):555-64. PMID: 22070180.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    106. MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10; 36(1):161-8. PMID: 21983143.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    107. Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training for child obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2011 Nov; 50(11):1149-61. PMID: 22024003.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    108. Genome-wide association study of the child behavior checklist dysregulation profile. J Am Acad Child Adolesc Psychiatry. 2011 Aug; 50(8):807-17.e8. Mick E, McGough J, Loo S, Doyle AE, Wozniak J, Wilens TE, Smalley S, McCracken J, Biederman J, Faraone SV. PMID: 21784300.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    109. The role of treatment expectancy in youth receiving exposure-based CBT for obsessive compulsive disorder. Behav Res Ther. 2011 Sep; 49(9):536-43. PMID: 21723534.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    110. Suicide attempts and nonsuicidal self-injury in the treatment of resistant depression in adolescents: findings from the TORDIA study. J Am Acad Child Adolesc Psychiatry. 2011 Aug; 50(8):772-81. PMID: 21784297.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    111. Diminished gray matter within the hypothalamus in autism disorder: a potential link to hormonal effects? Biol Psychiatry. 2011 Aug 01; 70(3):278-82. Kurth F, Narr KL, Woods RP, O'Neill J, Alger JR, Caplan R, McCracken JT, Toga AW, Levitt JG. PMID: 21531390.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    112. Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder. . 2011 Jun; 156B(4):472-7. Samuels J, Wang Y, Riddle MA, Greenberg BD, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Grados MA, Knowles JA, Piacentini J, Cullen B, Bienvenu OJ, Rasmussen SA, Geller D, Pauls DL, Liang KY, Shugart YY, Nestadt G. PMID: 21445956.
      View in: PubMed   Mentions:
    113. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. J Clin Psychiatry. 2011 Mar; 72(3):388-96. Vitiello B, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller MB, Birmaher B, Ryan ND, Kennard B, Mayes TL, DeBar L, Lynch F, Dickerson J, Strober M, Suddath R, McCracken JT, Spirito A, Onorato M, Zelazny J, Porta G, Iyengar S, Brent DA. PMID: 21208583.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    114. Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings. Arch Gen Psychiatry. 2011 Mar; 68(3):253-62. PMID: 21383263.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    115. Separation anxiety disorder in OCD. Depress Anxiety. 2011 Mar; 28(3):256-62. Mroczkowski MM, Goes FS, Riddle MA, Grados MA, Bienvenu OJ, Greenberg BD, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Knowles JA, Piacentini J, Cullen B, Rasmussen SA, Geller DA, Pauls DL, Liang KY, Nestadt G, Samuels JF. PMID: 21308883.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    116. Impact of physical and sexual abuse on treatment response in the Treatment of Resistant Depression in Adolescent Study (TORDIA). J Am Acad Child Adolesc Psychiatry. 2011 Mar; 50(3):293-301. Shamseddeen W, Asarnow JR, Clarke G, Vitiello B, Wagner KD, Birmaher B, Keller MB, Emslie G, Iyengar S, Ryan ND, McCracken JT, Porta G, Mayes T, Brent DA. PMID: 21334569.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    117. Atypical EEG beta asymmetry in adults with ADHD. Neuropsychologia. 2010 Oct; 48(12):3532-9. Hale TS, Smalley SL, Walshaw PD, Hanada G, Macion J, McCracken JT, McGough JJ, Loo SK. PMID: 20705076.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    118. Comparison of clinical features among youth with tic disorders, obsessive-compulsive disorder (OCD), and both conditions. Psychiatry Res. 2010 Jul 30; 178(2):317-22. Lewin AB, Chang S, McCracken J, McQueen M, Piacentini J. PMID: 20488548.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    119. Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010 Sep; 49(9):898-905.e3. Mick E, Todorov A, Smalley S, Hu X, Loo S, Todd RD, Biederman J, Byrne D, Dechairo B, Guiney A, McCracken J, McGough J, Nelson SF, Reiersen AM, Wilens TE, Wozniak J, Neale BM, Faraone SV. PMID: 20732626.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    120. Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. J Child Adolesc Psychopharmacol. 2010 Apr; 20(2):83-93. Arnold LE, Farmer C, Kraemer HC, Davies M, Witwer A, Chuang S, DiSilvestro R, McDougle CJ, McCracken J, Vitiello B, Aman MG, Scahill L, Posey DJ, Swiezy NB. PMID: 20415603.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    121. Familial clustering and DRD4 effects on electroencephalogram measures in multiplex families with attention deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010 Apr; 49(4):368-77. Loo SK, Hale ST, Hanada G, Macion J, Shrestha A, McGough JJ, McCracken JT, Nelson S, Smalley SL. PMID: 20410729.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    122. Manganese in children with attention-deficit/hyperactivity disorder: relationship with methylphenidate exposure. J Child Adolesc Psychopharmacol. 2010 Apr; 20(2):113-8. Farias AC, Cunha A, Benko CR, McCracken JT, Costa MT, Farias LG, Cordeiro ML. PMID: 20415606.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    123. Clinical characteristics of anxiety disordered youth. J Anxiety Disord. 2010 Apr; 24(3):360-5. Kendall PC, Compton SN, Walkup JT, Birmaher B, Albano AM, Sherrill J, Ginsburg G, Rynn M, McCracken J, Gosch E, Keeton C, Bergman L, Sakolsky D, Suveg C, Iyengar S, March J, Piacentini J. PMID: 20206470.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    124. Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity. J Child Adolesc Psychopharmacol. 2010 Feb; 20(1):1-5. McCracken JT, Aman MG, McDougle CJ, Tierney E, Shiraga S, Whelan F, Arnold LE, Posey D, Ritz L, Vitiello B, Scahill L. PMID: 20166790.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    125. Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods. Child Adolesc Psychiatry Ment Health. 2010 Jan 05; 4:1. Compton SN, Walkup JT, Albano AM, Piacentini JC, Birmaher B, Sherrill JT, Ginsburg GS, Rynn MA, McCracken JT, Waslick BD, Iyengar S, Kendall PC, March JS. PMID: 20051130.
      View in: PubMed   Mentions:
    126. Clinical and cognitive correlates of depressive symptoms among youth with obsessive compulsive disorder. J Clin Child Adolesc Psychol. 2010; 39(5):616-26. Peris TS, Bergman RL, Asarnow JR, Langley A, McCracken JT, Piacentini J. PMID: 20706915.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    127. Correlates of insight among youth with obsessive-compulsive disorder. J Child Psychol Psychiatry. 2010 May; 51(5):603-11. Lewin AB, Bergman RL, Peris TS, Chang S, McCracken JT, Piacentini J. PMID: 20039994.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    128. ADHD familial loading and abnormal EEG alpha asymmetry in children with ADHD. J Psychiatr Res. 2010 Jul; 44(9):605-15. Hale TS, Smalley SL, Dang J, Hanada G, Macion J, McCracken JT, McGough JJ, Loo SK. PMID: 20006344.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    129. A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2009 Dec; 48(12):1155-64. McGough JJ, McCracken JT, Loo SK, Manganiello M, Leung MC, Tietjens JR, Trinh T, Baweja S, Suddath R, Smalley SL, Hellemann G, Sugar CA. PMID: 19858760.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    130. Widespread cortical thinning is a robust anatomical marker for attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2009 Oct; 48(10):1014-1022. Narr KL, Woods RP, Lin J, Kim J, Phillips OR, Del'Homme M, Caplan R, Toga AW, McCracken JT, Levitt JG. PMID: 19730275.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    131. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Res. 2009 Sep 30; 169(2):124-31. Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, McCracken JT, Fava M, Iosifescu D, Greenwald S. PMID: 19712979.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    132. Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psychopharmacol. 2009 Aug; 29(4):372-7. Leuchter AF, McCracken JT, Hunter AM, Cook IA, Alpert JE. PMID: 19593178.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    133. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry. 2009 Jun; 66(6):583-90. King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L. PMID: 19487623.
      View in: PubMed   Mentions: 116     Fields:    Translation:Humans
    134. Cortical activity patterns in ADHD during arousal, activation and sustained attention. Neuropsychologia. 2009 Aug; 47(10):2114-9. Loo SK, Hale TS, Macion J, Hanada G, McGough JJ, McCracken JT, Smalley SL. PMID: 19393254.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    135. Atypical alpha asymmetry in adults with ADHD. Neuropsychologia. 2009 Aug; 47(10):2082-8. Hale TS, Smalley SL, Hanada G, Macion J, McCracken JT, McGough JJ, Loo SK. PMID: 19467358.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    136. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. J Am Acad Child Adolesc Psychiatry. 2009 Mar; 48(3):330-339. Asarnow JR, Emslie G, Clarke G, Wagner KD, Spirito A, Vitiello B, Iyengar S, Shamseddeen W, Ritz L, Birmaher B, Ryan N, Kennard B, Mayes T, DeBar L, McCracken J, Strober M, Suddath R, Leonard H, Porta G, Keller M, Brent D. PMID: 19182688.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    137. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry. 2009 Apr; 166(4):418-26. Brent DA, Emslie GJ, Clarke GN, Asarnow J, Spirito A, Ritz L, Vitiello B, Iyengar S, Birmaher B, Ryan ND, Zelazny J, Onorato M, Kennard B, Mayes TL, Debar LL, McCracken JT, Strober M, Suddath R, Leonard H, Porta G, Keller MB. PMID: 19223438.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    138. Trial design challenges when combining medication and parent training in children with pervasive developmental disorders. J Autism Dev Disord. 2009 May; 39(5):720-9. Scahill L, Aman MG, McDougle CJ, Arnold LE, McCracken JT, Handen B, Johnson C, Dziura J, Butter E, Sukhodolsky D, Swiezy N, Mulick J, Stigler K, Bearss K, Ritz L, Wagner A, Vitiello B. PMID: 19096921.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    139. Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. . 2008 Dec 05; 147B(8):1392-8. Zhou K, Dempfle A, Arcos-Burgos M, Bakker SC, Banaschewski T, Biederman J, Buitelaar J, Castellanos FX, Doyle A, Ebstein RP, Ekholm J, Forabosco P, Franke B, Freitag C, Friedel S, Gill M, Hebebrand J, Hinney A, Jacob C, Lesch KP, Loo SK, Lopera F, McCracken JT, McGough JJ, Meyer J, Mick E, Miranda A, Muenke M, Mulas F, Nelson SF, Nguyen TT, Oades RD, Ogdie MN, Palacio JD, Pineda D, Reif A, Renner TJ, Roeyers H, Romanos M, Rothenberger A, Schäfer H, Sergeant J, Sinke RJ, Smalley SL, Sonuga-Barke E, Steinhausen HC, van der Meulen E, Walitza S, Warnke A, Lewis CM, Faraone SV, Asherson P. PMID: 18988193.
      View in: PubMed   Mentions:
    140. Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. . 2008 Dec 05; 147B(8):1488-94. Lu AT, Ogdie MN, Järvelin MR, Moilanen IK, Loo SK, McCracken JT, McGough JJ, Yang MH, Peltonen L, Nelson SF, Cantor RM, Smalley SL. PMID: 18213623.
      View in: PubMed   Mentions:
    141. Reduced white matter integrity in attention-deficit hyperactivity disorder. Neuroreport. 2008 Nov 19; 19(17):1705-8. Hamilton LS, Levitt JG, O'Neill J, Alger JR, Luders E, Phillips OR, Caplan R, Toga AW, McCracken J, Narr KL. PMID: 18841089.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    142. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008 Dec 25; 359(26):2753-66. Walkup JT, Albano AM, Piacentini J, Birmaher B, Compton SN, Sherrill JT, Ginsburg GS, Rynn MA, McCracken J, Waslick B, Iyengar S, March JS, Kendall PC. PMID: 18974308.
      View in: PubMed   Mentions: 305     Fields:    Translation:Humans
    143. Decreased callosal thickness in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2009 Jan 01; 65(1):84-8. Luders E, Narr KL, Hamilton LS, Phillips OR, Thompson PM, Valle JS, Del'Homme M, Strickland T, McCracken JT, Toga AW, Levitt JG. PMID: 18842255.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    144. CBCL pediatric bipolar disorder profile and ADHD: comorbidity and quantitative trait loci analysis. J Am Acad Child Adolesc Psychiatry. 2008 Oct; 47(10):1151-7. McGough JJ, Loo SK, McCracken JT, Dang J, Clark S, Nelson SF, Smalley SL. PMID: 18724256.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    145. Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome. J Child Adolesc Psychopharmacol. 2008 Oct; 18(5):501-8. McCracken JT, Suddath R, Chang S, Thakur S, Piacentini J. PMID: 18928414.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    146. Correlates of accommodation of pediatric obsessive-compulsive disorder: parent, child, and family characteristics. J Am Acad Child Adolesc Psychiatry. 2008 Oct; 47(10):1173-81. Peris TS, Bergman RL, Langley A, Chang S, McCracken JT, Piacentini J. PMID: 18724255.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    147. Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord. 2009 Mar; 39(3):405-13. Nikolov RN, Bearss KE, Lettinga J, Erickson C, Rodowski M, Aman MG, McCracken JT, McDougle CJ, Tierney E, Vitiello B, Arnold LE, Shah B, Posey DJ, Ritz L, Scahill L. PMID: 18791817.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    148. Evidence for potential relationship between SLC1A1 and a putative genetic linkage region on chromosome 14q to obsessive-compulsive disorder with compulsive hoarding. . 2008 Sep 05; 147B(6):1000-2. Liang KY, Wang Y, Shugart YY, Grados M, Fyer AJ, Rauch S, Murphy D, McCracken J, Rasmussen S, Cullen B, Hoehn-Saric R, Greenberg B, Pinto A, Knowles J, Piacentini J, Pauls D, Bienvenu O, Riddle M, Samuels J, Nestadt G. PMID: 18286588.
      View in: PubMed   Mentions:
    149. Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. J Autism Dev Disord. 2009 Mar; 39(3):395-404. Jahromi LB, Kasari CL, McCracken JT, Lee LS, Aman MG, McDougle CJ, Scahill L, Tierney E, Arnold LE, Vitiello B, Ritz L, Witwer A, Kustan E, Ghuman J, Posey DJ. PMID: 18752063.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    150. Cognitive functioning in affected sibling pairs with ADHD: familial clustering and dopamine genes. J Child Psychol Psychiatry. 2008 Sep; 49(9):950-7. Loo SK, Rich EC, Ishii J, McGough J, McCracken J, Nelson S, Smalley SL. PMID: 18665883.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    151. Sex-specific clinical correlates of hoarding in obsessive-compulsive disorder. Behav Res Ther. 2008 Sep; 46(9):1040-6. Samuels JF, Bienvenu OJ, Pinto A, Murphy DL, Piacentini J, Rauch SL, Fyer AJ, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Cullen B, Riddle MA, Rasmussen SA, Pauls DL, Liang KY, Hoehn-Saric R, Pulver AE, Nestadt G. PMID: 18692168.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    152. Further development of YBOCS dimensions in the OCD Collaborative Genetics study: symptoms vs. categories. Psychiatry Res. 2008 Jul 15; 160(1):83-93. Pinto A, Greenberg BD, Grados MA, Bienvenu OJ, Samuels JF, Murphy DL, Hasler G, Stout RL, Rauch SL, Shugart YY, Pauls DL, Knowles JA, Fyer AJ, McCracken JT, Piacentini J, Wang Y, Willour VL, Cullen B, Liang KY, Hoehn-Saric R, Riddle MA, Rasmussen SA, Nestadt G. PMID: 18514325.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    153. Cognitive effects of risperidone in children with autism and irritable behavior. J Child Adolesc Psychopharmacol. 2008 Jun; 18(3):227-36. Aman MG, Hollway JA, McDougle CJ, Scahill L, Tierney E, McCracken JT, Arnold LE, Vitiello B, Ritz L, Gavaletz A, Cronin P, Swiezy N, Wheeler C, Koenig K, Ghuman JK, Posey DJ. PMID: 18582177.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    154. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008 Feb 27; 299(8):901-913. Brent D, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller M, Vitiello B, Ritz L, Iyengar S, Abebe K, Birmaher B, Ryan N, Kennard B, Hughes C, DeBar L, McCracken J, Strober M, Suddath R, Spirito A, Leonard H, Melhem N, Porta G, Onorato M, Zelazny J. PMID: 18314433.
      View in: PubMed   Mentions: 141     Fields:    Translation:Humans
    155. Demographic and clinical characteristics associated with treatment status in family members with obsessive-compulsive disorder. Depress Anxiety. 2008; 25(3):218-24. Cullen B, Samuels JF, Pinto A, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Greenberg BD, Knowles JA, Piacentini J, Bienvenu OJ, Grados MA, Riddle MA, Rasmussen SA, Pauls DL, Willour VL, Shugart YY, Liang KY, Hoehn-Saric R, Nestadt G. PMID: 17345603.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    156. Executive functioning among Finnish adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007 Dec; 46(12):1594-604. Loo SK, Humphrey LA, Tapio T, Moilanen IK, McGough JJ, McCracken JT, Yang MH, Dang J, Taanila A, Ebeling H, Järvelin MR, Smalley SL. PMID: 18030081.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    157. Prevalence and psychiatric comorbidity of attention-deficit/hyperactivity disorder in an adolescent Finnish population. J Am Acad Child Adolesc Psychiatry. 2007 Dec; 46(12):1575-83. Smalley SL, McGough JJ, Moilanen IK, Loo SK, Taanila A, Ebeling H, Hurtig T, Kaakinen M, Humphrey LA, McCracken JT, Varilo T, Yang MH, Nelson SF, Peltonen L, Järvelin MR. PMID: 18030079.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansPHPublic Health
    158. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. J Atten Disord. 2008 Jan; 11(4):470-81. Spencer TJ, Sallee FR, Gilbert DL, Dunn DW, McCracken JT, Coffey BJ, Budman CL, Ricardi RK, Leonard HL, Allen AJ, Milton DR, Feldman PD, Kelsey DK, Geller DA, Linder SL, Lewis DW, Winner PK, Kurlan RM, Mintz M. PMID: 17934184.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    159. Neurocognitive correlates of child obsessive compulsive disorder and Tourette syndrome. J Clin Exp Neuropsychol. 2007 Oct; 29(7):724-33. Chang SW, McCracken JT, Piacentini JC. PMID: 17896198.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    160. Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):635-46. Swanson JM, Moyzis RK, McGough JJ, McCracken JT, Riddle MA, Kollins SH, Greenhill LL, Abikoff HB, Wigal T, Wigal SB, Posner K, Skrobala AM, Davies M, Ghuman JK, Cunningham C, Vitiello B, Stehli A, Smalley SL, Grady D. PMID: 17979583.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    161. Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):563-80. Ghuman JK, Riddle MA, Vitiello B, Greenhill LL, Chuang SZ, Wigal SB, Kollins SH, Abikoff HB, McCracken JT, Kastelic E, Scharko AM, McGough JJ, Murray DW, Evans L, Swanson JM, Wigal T, Posner K, Cunningham C, Davies M, Skrobala AM. PMID: 17979578.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    162. Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):581-92. Abikoff HB, Vitiello B, Riddle MA, Cunningham C, Greenhill LL, Swanson JM, Chuang SZ, Davies M, Kastelic E, Wigal SB, Evans L, Ghuman JK, Kollins SH, McCracken JT, McGough JJ, Murray DW, Posner K, Skrobala AM, Wigal T. PMID: 17979579.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    163. Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):593-604. Vitiello B, Abikoff HB, Chuang SZ, Kollins SH, McCracken JT, Riddle MA, Swanson JM, Wigal T, McGough JJ, Ghuman JK, Wigal SB, Skrobala AM, Davies M, Posner K, Cunningham C, Greenhill LL. PMID: 17979580.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    164. Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):621-34. Hardy KK, Kollins SH, Murray DW, Riddle MA, Greenhill L, Cunningham C, Abikoff HB, McCracken JT, Vitiello B, Davies M, McGough JJ, Posner K, Skrobala AM, Swanson JM, Wigal T, Wigal SB, Ghuman JK, Chuang SZ. PMID: 17979582.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    165. Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):605-20. Murray DW, Kollins SH, Hardy KK, Abikoff HB, Swanson JM, Cunningham C, Vitiello B, Riddle MA, Davies M, Greenhill LL, McCracken JT, McGough JJ, Posner K, Skrobala AM, Wigal T, Wigal SB, Ghuman JK, Chuang SZ. PMID: 17979581.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    166. Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):547-62. Posner K, Melvin GA, Murray DW, Gugga SS, Fisher P, Skrobala A, Cunningham C, Vitiello B, Abikoff HB, Ghuman JK, Kollins S, Wigal SB, Wigal T, McCracken JT, McGough JJ, Kastelic E, Boorady R, Davies M, Chuang SZ, Swanson JM, Riddle MA, Greenhill LL. PMID: 17979577.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    167. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning. J Abnorm Child Psychol. 2008 Jan; 36(1):117-28. Sukhodolsky DG, Scahill L, Gadow KD, Arnold LE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Williams White S, Lecavalier L, Vitiello B. PMID: 17674186.
      View in: PubMed   Mentions: 124     Fields:    Translation:Humans
    168. Atypical brain activation during simple & complex levels of processing in adult ADHD: an fMRI study. J Atten Disord. 2007 Sep; 11(2):125-40. Hale TS, Bookheimer S, McGough JJ, Phillips JM, McCracken JT. PMID: 17494829.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    169. Significant linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. Am J Psychiatry. 2007 Mar; 164(3):493-9. Samuels J, Shugart YY, Grados MA, Willour VL, Bienvenu OJ, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy DL, Wang Y, Pinto A, Fyer AJ, Piacentini J, Pauls DL, Cullen B, Rasmussen SA, Hoehn-Saric R, Valle D, Liang KY, Riddle MA, Nestadt G. PMID: 17329475.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    170. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry. 2007 Feb 15; 61(4):538-44. Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, Vitiello B, Chuang SZ, Davies M, Ramadan Y, Witwer AN, Swiezy NB, Cronin P, Shah B, Carroll DH, Young C, Wheeler C, McDougle CJ. PMID: 17276750.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    171. The association of DRD4 and novelty seeking is found in a nonhuman primate model. Psychiatr Genet. 2007 Feb; 17(1):23-7. Bailey JN, Breidenthal SE, Jorgensen MJ, McCracken JT, Fairbanks LA. PMID: 17167341.
      View in: PubMed   Mentions: 30     Fields:    Translation:Animals
    172. CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry. 2007 Feb; 46(2):242-51. Michelson D, Read HA, Ruff DD, Witcher J, Zhang S, McCracken J. PMID: 17242628.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    173. Dietary status and impact of risperidone on nutritional balance in children with autism: a pilot study. J Intellect Dev Disabil. 2006 Dec; 31(4):204-9. Lindsay RL, Eugene Arnold L, Aman MG, Vitiello B, Posey DJ, McDougle CJ, Scahill L, Pachler M, McCracken JT, Tierney E, Bozzolo D. PMID: 17178532.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    174. Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study. Psychopharmacology (Berl). 2007 Mar; 191(1):149-57. Tierney E, Aman M, Stout D, Pappas K, Arnold LE, Vitiello B, Scahill L, McDougle C, McCracken J, Wheeler C, Martin A, Posey D, Shah B. PMID: 17123125.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    175. Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry. 2006 Nov; 45(11):1294-1303. Wigal T, Greenhill L, Chuang S, McGOUGH J, Vitiello B, Skrobala A, Swanson J, Wigal S, Abikoff H, Kollins S, McCRACKEN J, Riddle M, Posner K, Ghuman J, Davies M, Thorp B, Stehli A. PMID: 17028508.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    176. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006 Nov; 45(11):1284-1293. Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, McGough J, Wigal S, Wigal T, Vitiello B, Skrobala A, Posner K, Ghuman J, Cunningham C, Davies M, Chuang S, Cooper T. PMID: 17023867.
      View in: PubMed   Mentions: 99     Fields:    Translation:Humans
    177. Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS). J Am Acad Child Adolesc Psychiatry. 2006 Nov; 45(11):1275-1283. Kollins S, Greenhill L, Swanson J, Wigal S, Abikoff H, McCRACKEN J, Riddle M, McGOUGH J, Vitiello B, Wigal T, Skrobala A, Posner K, Ghuman J, Davies M, Cunningham C, Bauzo A. PMID: 17023869.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    178. Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006 Nov; 45(11):1314-1322. McGOUGH J, McCRACKEN J, Swanson J, Riddle M, Kollins S, Greenhill L, Abikoff H, Davies M, Chuang S, Wigal T, Wigal S, Posner K, Skrobala A, Kastelic E, Ghuman J, Cunningham C, Shigawa S, Moyzis R, Vitiello B. PMID: 17023870.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    179. Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry. 2006 Nov; 45(11):1304-1313. Swanson J, Greenhill L, Wigal T, Kollins S, Stehli A, Davies M, Chuang S, Vitiello B, Skrobala A, Posner K, Abikoff H, Oatis M, McCRACKEN J, McGOUGH J, Riddle M, Ghuman J, Cunningham C, Wigal S. PMID: 17023868.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    180. Familiality of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD Collaborative Genetics Study. Biol Psychiatry. 2007 Mar 01; 61(5):617-25. Hasler G, Pinto A, Greenberg BD, Samuels J, Fyer AJ, Pauls D, Knowles JA, McCracken JT, Piacentini J, Riddle MA, Rauch SL, Rasmussen SA, Willour VL, Grados MA, Cullen B, Bienvenu OJ, Shugart YY, Liang KY, Hoehn-Saric R, Wang Y, Ronquillo J, Nestadt G, Murphy DL. PMID: 17027929.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    181. A prospective open trial of guanfacine in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006 Oct; 16(5):589-98. Scahill L, Aman MG, McDougle CJ, McCracken JT, Tierney E, Dziura J, Arnold LE, Posey D, Young C, Shah B, Ghuman J, Ritz L, Vitiello B. PMID: 17069547.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    182. Adult attention deficit hyperactivity disorder: moving beyond DSM-IV. Am J Psychiatry. 2006 Oct; 163(10):1673-5. McGough JJ, McCracken JT. PMID: 17012671.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    183. Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry. 2006 Sep; 45(9):1114-23. Scahill L, McDougle CJ, Williams SK, Dimitropoulos A, Aman MG, McCracken JT, Tierney E, Arnold LE, Cronin P, Grados M, Ghuman J, Koenig K, Lam KS, McGough J, Posey DJ, Ritz L, Swiezy NB, Vitiello B. PMID: 16926619.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    184. Hoarding in obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. Behav Res Ther. 2007 Apr; 45(4):673-86. Samuels JF, Bienvenu OJ, Pinto A, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Grados MA, Greenberg BD, Knowles JA, Piacentini J, Cannistraro PA, Cullen B, Riddle MA, Rasmussen SA, Pauls DL, Willour VL, Shugart YY, Liang KY, Hoehn-Saric R, Nestadt G. PMID: 16824483.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    185. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry. 2006 Jul; 63(7):808-16. Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London ED, McCracken JT. PMID: 16818870.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCells
    186. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006 Jun; 45(6):642-657. Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, McCRACKEN JT, Swanson JM, Lopez M. PMID: 16721314.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    187. Effects of short- and long-term risperidone treatment on prolactin levels in children with autism. Biol Psychiatry. 2007 Feb 15; 61(4):545-50. Anderson GM, Scahill L, McCracken JT, McDougle CJ, Aman MG, Tierney E, Arnold LE, Martin A, Katsovich L, Posey DJ, Shah B, Vitiello B. PMID: 16730335.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    188. Validity of the autism diagnostic interview-revised. Am J Ment Retard. 2006 May; 111(3):199-215. Lecavalier L, Aman MG, Scahill L, McDougle CJ, McCracken JT, Vitiello B, Tierney E, Arnold LE, Ghuman JK, Loftin RL, Cronin P, Koenig K, Posey DJ, Martin A, Hollway J, Lee LS, Kau AS. PMID: 16597187.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    189. The OCD collaborative genetics study: methods and sample description. . 2006 Apr 05; 141B(3):201-7. Samuels JF, Riddle MA, Greenberg BD, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Grados MA, Pinto A, Knowles JA, Piacentini J, Cannistraro PA, Cullen B, Bienvenu OJ, Rasmussen SA, Pauls DL, Willour VL, Shugart YY, Liang KY, Hoehn-Saric R, Nestadt G. PMID: 16511842.
      View in: PubMed   Mentions:
    190. Risperidone and adaptive behavior in children with autism. J Am Acad Child Adolesc Psychiatry. 2006 Apr; 45(4):431-9. Williams SK, Scahill L, Vitiello B, Aman MG, Arnold LE, McDougle CJ, McCracken JT, Tierney E, Ritz L, Posey DJ, Swiezy NB, Hollway J, Cronin P, Ghuman J, Wheeler C, Cicchetti D, Sparrow S. PMID: 16601648.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    191. Relationship of family environment and parental psychiatric diagnosis to impairment in ADHD. J Am Acad Child Adolesc Psychiatry. 2006 Mar; 45(3):346-354. Pressman LJ, Loo SK, Carpenter EM, Asarnow JR, Lynn D, McCRACKEN JT, MCGough JJ, Lubke GH, Yang MH, Smalley SL. PMID: 16540820.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    192. Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone. J Clin Psychopharmacol. 2005 Dec; 25(6):565-9. Vitiello B, Davies M, Arnold LE, McDougle CJ, Aman M, McCracken JT, Scahill L, Tierney E, Posey DJ, Swiezy NB, Koenig K. PMID: 16282839.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    193. Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol. 2005 Dec; 15(6):869-84. Aman MG, Arnold LE, McDougle CJ, Vitiello B, Scahill L, Davies M, McCracken JT, Tierney E, Nash PL, Posey DJ, Chuang S, Martin A, Shah B, Gonzalez NM, Swiezy NB, Ritz L, Koenig K, McGough J, Ghuman JK, Lindsay RL. PMID: 16379507.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    194. Atypical brain laterality in adults with ADHD during dichotic listening for emotional intonation and words. Neuropsychologia. 2006; 44(6):896-904. Hale TS, Zaidel E, McGough JJ, Phillips JM, McCracken JT. PMID: 16216289.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    195. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry. 2005 Sep; 162(9):1621-7. McGough JJ, Smalley SL, McCracken JT, Yang M, Del'Homme M, Lynn DE, Loo S. PMID: 16135620.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    196. Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment. J Child Adolesc Psychopharmacol. 2005 Aug; 15(4):581-7. McCracken JT, Hanna GL. PMID: 16190790.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    197. A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder. J Atten Disord. 2005 Aug; 9(1):275-89. Wigal SB, McGough JJ, McCracken JT, Biederman J, Spencer TJ, Posner KL, Wigal TL, Kollins SH, Clark TM, Mays DA, Zhang Y, Tulloch SJ. PMID: 16371674.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    198. Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2005 Jun; 44(6):530-8. McGough JJ, Biederman J, Wigal SB, Lopez FA, McCracken JT, Spencer T, Zhang Y, Tulloch SJ. PMID: 15908835.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    199. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry. 2005 Jun; 162(6):1142-8. McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, Koenig K, McGough JJ, Ritz L, Vitiello B. PMID: 15930063.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCTClinical Trials
    200. Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2005 May; 44(5):418-27. Abikoff H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon DJ, Ritz L. PMID: 15843763.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    201. Temperament and character profiles and the dopamine D4 receptor gene in ADHD. Am J Psychiatry. 2005 May; 162(5):906-13. Lynn DE, Lubke G, Yang M, McCracken JT, McGough JJ, Ishii J, Loo SK, Nelson SF, Smalley SL. PMID: 15863792.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    202. Abnormal development of the anterior cingulate in childhood-onset schizophrenia: a preliminary quantitative MRI study. Psychiatry Res. 2005 Apr 30; 138(3):221-33. Marquardt RK, Levitt JG, Blanton RE, Caplan R, Asarnow R, Siddarth P, Fadale D, McCracken JT, Toga AW. PMID: 15854790.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    203. Research knowledge among parents of children participating in a randomized clinical trial. J Am Acad Child Adolesc Psychiatry. 2005 Feb; 44(2):145-9. Vitiello B, Aman MG, Scahill L, McCracken JT, McDougle CJ, Tierney E, Davies M, Arnold LE. PMID: 15689727.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    204. Safety issues with drug therapies for autism spectrum disorders. J Clin Psychiatry. 2005; 66 Suppl 10:32-7. McCracken JT. PMID: 16401148.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    205. Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 2004 Nov; 43(11):1397-405. Emslie GJ, Heiligenstein JH, Hoog SL, Wagner KD, Findling RL, McCracken JT, Nilsson ME, Jacobson JG. PMID: 15502599.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    206. Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. Am J Hum Genet. 2004 Oct; 75(4):661-8. Ogdie MN, Fisher SE, Yang M, Ishii J, Francks C, Loo SK, Cantor RM, McCracken JT, McGough JJ, Smalley SL, Nelson SF. PMID: 15297934.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    207. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data. Am J Psychiatry. 2004 Jun; 161(6):1125-7. Martin A, Scahill L, Anderson GM, Aman M, Arnold LE, McCracken J, McDougle CJ, Tierney E, Chuang S, Vitiello B. PMID: 15169706.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    208. Gender differences in the left inferior frontal gyrus in normal children. Neuroimage. 2004 Jun; 22(2):626-36. Blanton RE, Levitt JG, Peterson JR, Fadale D, Sporty ML, Lee M, To D, Mormino EC, Thompson PM, McCracken JT, Toga AW. PMID: 15193591.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    209. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia. Neuroimage. 2004 Apr; 21(4):1781-9. O'Neill J, Levitt J, Caplan R, Asarnow R, McCracken JT, Toga AW, Alger JR. PMID: 15050598.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    210. Second-generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol. 2004; 14(3):372-94. Cheng-Shannon J, McGough JJ, Pataki C, McCracken JT. PMID: 15650494.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    211. Impairment in childhood anxiety disorders: preliminary examination of the child anxiety impact scale-parent version. J Child Adolesc Psychopharmacol. 2004; 14(1):105-14. Langley AK, Bergman RL, McCracken J, Piacentini JC. PMID: 15142397.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    212. Proton magnetic resonance spectroscopic imaging of the brain in childhood autism. Biol Psychiatry. 2003 Dec 15; 54(12):1355-66. Levitt JG, O'Neill J, Blanton RE, Smalley S, Fadale D, McCracken JT, Guthrie D, Toga AW, Alger JR. PMID: 14675799.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    213. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents. Am J Psychiatry. 2003 Aug; 160(8):1442-52. Davanzo P, Yue K, Thomas MA, Belin T, Mintz J, Venkatraman TN, Santoro E, Barnett S, McCracken J. PMID: 12900307.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    214. Cortical sulcal maps in autism. Cereb Cortex. 2003 Jul; 13(7):728-35. Levitt JG, Blanton RE, Smalley S, Thompson PM, Guthrie D, McCracken JT, Sadoun T, Heinichen L, Toga AW. PMID: 12816888.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    215. How can we improve the assessment of safety in child and adolescent psychopharmacology? J Am Acad Child Adolesc Psychiatry. 2003 Jun; 42(6):634-41. Vitiello B, Riddle MA, Greenhill LL, March JS, Levine J, Schachar RJ, Abikoff H, Zito JM, McCracken JT, Walkup JT, Findling RL, Robinson J, Cooper TB, Davies M, Varipatis E, Labellarte MJ, Scahill L, Capasso L. PMID: 12921470.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    216. Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000. J Am Acad Child Adolesc Psychiatry. 2003 Jun; 42(6):651-5. Greenhill LL, Vitiello B, Abikoff H, Levine J, March JS, Riddle MA, Capasso L, Cooper TB, Davies M, Fisher P, Findling RL, Fried J, Labellarte MJ, McCracken JT, McMahon D, Robinson J, Skrobala A, Scahill L, Varipatis E, Walkup JT, Zito JM. PMID: 12921472.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    217. Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall. J Am Acad Child Adolesc Psychiatry. 2003 Jun; 42(6):684-91. McGough JJ, Biederman J, Greenhill LL, McCracken JT, Spencer TJ, Posner K, Wigal S, Gornbein J, Tulloch S, Swanson JM. PMID: 12921476.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    218. Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2003 Jun; 42(6):673-83. McCracken JT, Biederman J, Greenhill LL, Swanson JM, McGough JJ, Spencer TJ, Posner K, Wigal S, Pataki C, Zhang Y, Tulloch S. PMID: 12921475.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    219. Review of safety assessment methods used in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry. 2003 Jun; 42(6):627-33. Greenhill LL, Vitiello B, Riddle MA, Fisher P, Shockey E, March JS, Levine J, Fried J, Abikoff H, Zito JM, McCracken JT, Findling RL, Robinson J, Cooper TB, Davies M, Varipatis E, Labellarte MJ, Scahill L, Walkup JT, Capasso L, Rosengarten J. PMID: 12921469.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    220. A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. Am J Hum Genet. 2003 May; 72(5):1268-79. Ogdie MN, Macphie IL, Minassian SL, Yang M, Fisher SE, Francks C, Cantor RM, McCracken JT, McGough JJ, Nelson SF, Monaco AP, Smalley SL. PMID: 12687500.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    221. Functional impairment in children and adolescents with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2003; 13 Suppl 1:S61-9. Piacentini J, Bergman RL, Keller M, McCracken J. PMID: 12880501.
      View in: PubMed   Mentions: 95     Fields:    Translation:Humans
    222. Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference. J Child Adolesc Psychopharmacol. 2003; 13(1):13-27. Carlson GA, Jensen PS, Findling RL, Meyer RE, Calabrese J, DelBello MP, Emslie G, Flynn L, Goodwin F, Hellander M, Kowatch R, Kusumakar V, Laughren T, Leibenluft E, McCracken J, Nottelmann E, Pine D, Sachs G, Shaffer D, Simar R, Strober M, Weller EB, Wozniak J, Youngstrom EA. PMID: 12804123.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    223. Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2003 Jan; 42(1):13-21. Walkup JT, Labellarte MJ, Riddle MA, Pine D, Greenhill L, Klein R, Davies M, Sweeney M, Fu C, Abikoff H, Hack S, Klee B, McCracken J, Bergman L, Piacentini J, March J, Compton S, Robinson J, O'Hara T, Baker S, Vitiello B, Ritz L, Roper M. PMID: 12500072.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    224. Concurrent validity of the anxiety disorders section of the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions. J Clin Child Adolesc Psychol. 2002 Sep; 31(3):335-42. Wood JJ, Piacentini JC, Bergman RL, McCracken J, Barrios V. PMID: 12149971.
      View in: PubMed   Mentions: 185     Fields:    Translation:Humans
    225. Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. Am J Hum Genet. 2002 Oct; 71(4):959-63. Smalley SL, Kustanovich V, Minassian SL, Stone JL, Ogdie MN, McGough JJ, McCracken JT, MacPhie IL, Francks C, Fisher SE, Cantor RM, Monaco AP, Nelson SF. PMID: 12187510.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    226. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002 Aug 01; 347(5):314-21. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D. PMID: 12151468.
      View in: PubMed   Mentions: 316     Fields:    Translation:HumansCTClinical Trials
    227. Prevalence and description of selective mutism in a school-based sample. J Am Acad Child Adolesc Psychiatry. 2002 Aug; 41(8):938-46. Bergman RL, Piacentini J, McCracken JT. PMID: 12162629.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    228. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet. 2002 May; 70(5):1183-96. Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL, Newbury DF, Crawford LR, Palmer CG, Woodward JA, Del'Homme M, Cantwell DP, Nelson SF, Monaco AP, Smalley SL. PMID: 11923911.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCells
    229. Childhood and early-onset anxiety: treatment and biomarker studies. J Clin Psychiatry. 2002; 63 Suppl 6:8-11. McCracken JT, Walkup JT, Koplewicz HS. PMID: 12027119.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    230. Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study. J Child Adolesc Psychopharmacol. 2002; 12(3):175-88. Walkup J, Labellarte M, Riddle MA, Pine DS, Greenhill L, Fairbanks J, Klein R, Davies M, Sweeney M, Abikoff H, Hack S, Klee B, Bergman RL, Lynn D, McCracken J, March J, Gammon P, Vitiello B, Ritz L, Roper M. PMID: 12427292.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    231. Open trial of cognitive behavior therapy for childhood obsessive-compulsive disorder. J Anxiety Disord. 2002; 16(2):207-19. Piacentini J, Bergman RL, Jacobs C, McCracken JT, Kretchman J. PMID: 12194545.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    232. Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Mol Psychiatry. 2000 Sep; 5(5):531-6. McCracken JT, Smalley SL, McGough JJ, Crawford L, Del'Homme M, Cantor RM, Liu A, Nelson SF. PMID: 11032387.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    James's Networks
    Concepts (558)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (35)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑